Download presentation
Presentation is loading. Please wait.
Published byDenis Short Modified over 6 years ago
1
Randomized comparison of new dual-antiplatelet therapy (aspirin, prasugrel) and triple- antiplatelet therapy (aspirin, clopidogrel, cilostazol) using P2Y12 point-of-care assay in patients with STEMI undergoing primary PCI Tae-Hyun Yang, Han-Young Jin, Kyu-Nam Choi, Ungjeong Do, Hyung Jun Kim, Sang-Ryul Chung, Jeong-Sook Seo, Jae-Sik Jang, Dae- Kyeong Kim, Dong-Soo Kim International Journal of Cardiology Volume 168, Issue 1, Pages (September 2013) DOI: /j.ijcard Copyright © 2012 Elsevier Ireland Ltd Terms and Conditions
2
Fig. 1 Schematic of study design.
International Journal of Cardiology , DOI: ( /j.ijcard ) Copyright © 2012 Elsevier Ireland Ltd Terms and Conditions
3
Fig. 2 Serial change of P2Y12 reaction unit values.
International Journal of Cardiology , DOI: ( /j.ijcard ) Copyright © 2012 Elsevier Ireland Ltd Terms and Conditions
4
Fig. 3 P2Y12 reaction unit values at discharge.
International Journal of Cardiology , DOI: ( /j.ijcard ) Copyright © 2012 Elsevier Ireland Ltd Terms and Conditions
5
Fig. 4 Individual P2Y12 reaction unit values according to treatment. Lines represent medians. International Journal of Cardiology , DOI: ( /j.ijcard ) Copyright © 2012 Elsevier Ireland Ltd Terms and Conditions
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.